For instance, SUVpeak has been associated with TGFβ pathway mutations in adenocarcinoma, highlighting the potential of radiogenomics to capture tumor heterogeneity and inform therapeutic decisions [17]. This evidence concerns the gene TGFB1 and adenocarcinoma.